NextRNA Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Out of Business

  • Employees
  • 27

Employees

  • Latest Deal Type
  • Liquidation

NextRNA General Information

Description

Developer of targeted therapeutics intended to discover novel non-coding ribonucleic acid responsible for the disease. The company's discovery platform identifies and modulates the RNA-binding protein responsible for the disease function of an ncRNA and disrupts the disease-related ncRNA-protein interaction, enabling medical practitioners to help cure a variety of diseases.

Contact Information

Formerly Known As
SeoRx Therapeutics
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • 40 Guest Street
  • Boston, MA 02135
  • United States
+1 (617)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 40 Guest Street
  • Boston, MA 02135
  • United States
+1 (617)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

NextRNA Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Bankruptcy: Liquidation 01-Aug-2025 Completed Bankruptcy: Liquidation
3. Early Stage VC (Series A) 01-Mar-2022 Completed Generating Revenue
2. Seed Round 12-Mar-2021 $9.3M $9.3M Completed Generating Revenue
1. Accelerator/Incubator Completed Startup
To view NextRNA’s complete valuation and funding history, request access »

NextRNA Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A
Seed
To view NextRNA’s complete cap table history, request access »

NextRNA Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of targeted therapeutics intended to discover novel non-coding ribonucleic acid responsible for the disease. T
Drug Discovery
Boston, MA
27 As of 2025

Waltham, MA
 

Thousand Oaks, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

NextRNA Competitors (2)

One of NextRNA’s 2 competitors is Arrakis Therapeutics, a Venture Capital-Backed company based in Waltham, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Arrakis Therapeutics Venture Capital-Backed Waltham, MA
Atara Biotherapeutics Formerly VC-backed Thousand Oaks, CA
You’re viewing 2 of 2 competitors. Get the full list »

NextRNA Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

NextRNA FAQs

  • When was NextRNA founded?

    NextRNA was founded in 2019.

  • Where is NextRNA headquartered?

    NextRNA is headquartered in Boston, MA.

  • What is the size of NextRNA?

    NextRNA has 27 total employees.

  • What industry is NextRNA in?

    NextRNA’s primary industry is Drug Discovery.

  • Is NextRNA a private or public company?

    NextRNA is a Private company.

  • What is NextRNA’s current revenue?

    The current revenue for NextRNA is .

  • How much funding has NextRNA raised over time?

    NextRNA has raised $56.1M.

  • Who are NextRNA’s competitors?

    Arrakis Therapeutics and Atara Biotherapeutics are competitors of NextRNA.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process